Genetico has received a patent for a panel developed by the company to search for somatic mutations in a tumor using the Onconetix next-generation sequencing method. Panel allows oncologists to obtain the most complete information about point mutations in the tumor to select an effective target therapy for cancer individually for each patient, taking into account the genetic features of his tumor.